Tarsus Pharmaceuticals Inc (TARS)
R&D Expenses
$31.01M
Quarterly · Period ending: · USD
TARS R&D Expenses
Latest reported$31.01Mperiod ending
Latest reported$31.01Mperiod ending
TARS Quarterly R&D Expenses ($225.25K → $31.01M)
Quarterly R&D Expenses
High-resolution chart · PNG
TARS r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 31,010,000 | |
| 22,351,000 | |
| 18,035,000 | |
| 16,283,999 | |
| 15,594,000 | |
| 14,409,000 | |
| 16,873,000 | |
| 12,128,000 | |
| 12,319,000 | |
| 12,066,000 | |
| 13,305,000 | |
| 12,105,000 | |
| 12,546,000 | |
| 12,356,000 | |
| 10,028,000 | |
| 10,912,000 | |
| 9,603,000 | |
| 12,081,000 | |
| 8,038,000 | |
| 10,209,000 | |
| 7,204,000 | |
| 16,261,000 | |
| 7,587,000 | |
| 7,991,000 | |
| 1,737,000 | |
| 1,512,000 | |
| 697,000 | |
| 399,000 | |
| 225,250 | |
| 225,250 |